Bidirectional relationship of mast cells-neurovascular unit communication in neuroinflammation and its involvement in POCD

Behavioural Brain Research

Volumn 322, Issue , 2017, Pages 60-69

  Li, Nana ^a   Zhang, Xiang ^a   Dong, Hongquan ^a   Hu, Youli ^a   Qian, Yanning ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Astrocyte; Blood brain barrier; Degenerative diseases; Mast cells; Microglia; Neuroinflammation; Neurovascular unit; Postoperative cognitive dysfunction

Indexed keywords

CEREBROLYSIN;

ADJUVANT THERAPY; BLOOD BRAIN BARRIER; CARDIOVASCULAR SYSTEM; CELL ACTIVATION; CELL COMMUNICATION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DISEASE ACTIVITY; DISEASE COURSE; GLIA; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INNATE IMMUNITY; MAST CELL; MEMORY DISORDER; MENTAL PERFORMANCE; NERVE POTENTIAL; NERVOUS SYSTEM INFLAMMATION; NEUROANATOMY; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROVASCULAR UNIT; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE COGNITIVE DYSFUNCTION; PSYCHOPATHY; REVIEW; VASCULAR DISEASE; ANIMAL; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PSYCHOLOGY;

ANIMALS; BLOOD-BRAIN BARRIER; COGNITIVE DYSFUNCTION; HUMANS; INFLAMMATION; MAST CELLS; NEUROIMMUNOMODULATION; POSTOPERATIVE COMPLICATIONS;

EID: 85009821078     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2017.01.006     Document Type: Review

References (140)

1. [1] Lu, S.M., Yu, C.J., Liu, Y.H., Dong, H.Q., Zhang, X., Zhang, S.S., Hu, L.Q., Zhang, F., Qian, Y.N., Gui, B., S100A8 contributes to postoperative cognitive dysfunction in mice undergoing tibial fracture surgery by activating the TLR4/MyD88 pathway. Brain Behav. Immun. 44 (2015), 221–234.
2. [2] McGeer, P.L., McGeer, E.G., The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol. 126 (2013), 479–497.
3. [3] Amor, S., Woodroofe, M.N., Innate and adaptive immune responses in neurodegeneration and repair. Immunology 141 (2014), 287–291.
4. [4] Vivekanantham, S., Shah, S., Dewji, R., Dewji, A., Khatri, C., Ologunde, R., Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair. Int. J. Neurosci. 125 (2015), 717–725.
5. [5] Zhang, S., Dong, H., Zhang, X., Li, N., Sun, J., Qian, Y., Cerebral mast cells contribute to postoperative cognitive dysfunction by promoting blood brain barrier disruption. Behav. Brain Res. 298 (2016), 158–166.
6. [6] Zlokovic, B.V., Neurodegeneration and the neurovascular unit. Nat. Med. 16 (2010), 1370–1371.
7. [7] Merlini, M., Meyer, E.P., Ulmann-Schuler, A., Nitsch, R.M., Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Acta Neuropathol. 122 (2011), 293–311.
8. [8] Hovens, I.B., Schoemaker, R.G., van der Zee, E.A., Heineman, E., Izaks, G.J., van Leeuwen, B.L., Thinking through postoperative cognitive dysfunction: how to bridge the gap between clinical and pre-clinical perspectives. Brain Behav. Immun. 26 (2012), 1169–1179.
9. [9] Didem, B., Huseyin, B., Osman, Y., Yasemin, B., Necati, G., Canan, T., Early effects of laparotomy and laparoscopy on bacterial behavior and proinflammatory cytokines on bacterial peritonitis in rats I: Escherichia coli. J. Pediatr. Surg. 43 (2008), 1494–1501.
10. [10] Kannan, S., Saadani-Makki, F., Muzik, O., Chakraborty, P., Mangner, T.J., Janisse, J., Romero, R., Chugani, D.C., Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET. J. Nucl. Med. 48 (2007), 946–954.
11. [11] Cibelli, M., Fidalgo, A.R., Terrando, N., Ma, D., Monaco, C., Feldmann, M., Takata, M., Lever, I.J., Nanchahal, J., Fanselow, M.S., Maze, M., Role of interleukin-1beta in postoperative cognitive dysfunction. Ann. Neurol. 68 (2010), 360–368.
12. [12] Terrando, N., Monaco, C., Ma, D., Foxwell, B.M., Feldmann, M., Maze, M., Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 20518–20522.
13. [13] Vacas, S., Degos, V., Tracey, K.J., Maze, M., High-mobility group box 1 protein initiates postoperative cognitive decline by engaging bone marrow-derived macrophages. Anesthesiology 120 (2014), 1160–1167.
14. [14] Rosczyk, H.A., Sparkman, N.L., Johnson, R.W., Neuroinflammation and cognitive function in aged mice following minor surgery. Exp. Gerontol. 43 (2008), 840–846.
15. [15] Nautiyal, K.M., Dailey, C.A., Jahn, J.L., Rodriquez, E., Son, N.H., Sweedler, J.V., Silver, R., Serotonin of mast cell origin contributes to hippocampal function. Eur. J. Neurosci. 36 (2012), 2347–2359.
16. [16] Rogers, M.P., Bloomingdale, K., Murawski, B.J., Soter, N.A., Reich, P., Austen, K.F., Mixed organic brain syndrome as a manifestation of systemic mastocytosis. Psychosom. Med. 48 (1986), 437–447.
17. [17] Nelissen, S., Lemmens, E., Geurts, N., Kramer, P., Maurer, M., Hendriks, J., Hendrix, S., The role of mast cells in neuroinflammation. Acta Neuropathol. 125 (2013), 637–650.
18. [18] Dropp, J.J., Mast cells in the central nervous system of several rodents. Anat. Rec. 174 (1972), 227–237.
19. [19] Manni, L., Micera, A., Pistillo, L., Aloe, L., Neonatal handling in EAE-susceptible rats alters NGF levels and mast cell distribution in the brain. Int. J. Dev. Neurosci. 16 (1998), 1–8.
20. [20] Beaven, M.A., Our perception of the mast cell from Paul Ehrlich to now. Eur. J. Immunol. 39 (2009), 11–25.
21. [21] Bischoff, S.C., Sellge, G., Mast cell hyperplasia: role of cytokines. Int. Arch. Allergy Immunol. 127 (2002), 118–122.
22. [22] Okayama, Y., Kawakami, T., Development, migration, and survival of mast cells. Immunol. Res. 34 (2006), 97–115.
23. [23] Hundley, T.R., Kit and Fc RI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 104 (2004), 2410–2417.
24. [24] Skaper, S.D., Giusti, P., Facci, L., Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J. 26 (2012), 3103–3117.
25. [25] Stone, K.D., Prussin, C., Metcalfe, D.D., IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol. 125 (2010), S73–S80.
26. [26] Cai, C., Cao, Z., Loughran, P.A., Kim, S., Darwiche, S., Korff, S., Billiar, T.R., Mast cells play a critical role in the systemic inflammatory response and end-organ injury resulting from trauma. J. Am. Coll. Surg. 213 (2011), 604–615.
27. [27] Roy, A., Ganesh, G., Sippola, H., Bolin, S., Sawesi, O., Dagalv, A., Schlenner, S.M., Feyerabend, T., Rodewald, H.R., Kjellen, L., Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation. J. Biol. Chem. 289 (2014), 237–250.
28. [28] Skaper, S.D., Facci, L., Kee, W.J., Strijbos, P.J., Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurones: a possible role for mast cells. J. Neurochem. 76 (2001), 47–55.
29. [29] Hagiyama, M., Furuno, T., Hosokawa, Y., Iino, T., Ito, T., Inoue, T., Nakanishi, M., Murakami, Y., Ito, A., Enhanced nerve-mast cell interaction by a neuronal short isoform of cell adhesion molecule-1. J. Immunol. 186 (2011), 5983–5992.
30. [30] Jin, Y., Silverman, A.J., Vannucci, S.J., Mast cell stabilization limits hypoxic-ischemic brain damage in the immature rat. Dev. Neurosci. 29 (2007), 373–384.
31. [31] Ikarashi, Y., Yuzurihara, M., Experimental anxiety induced by histaminergics in mast cell-deficient and congenitally normal mice. Pharmacol. Biochem. Behav. 72 (2002), 437–441.
32. [32] Donoso, A.O., Broitman, S.T., Effects of a histamine synthesis inhibitor and antihistamines on the sexual behavior of female rats. Psychopharmacology (Berl.) 66 (1979), 251–255.
33. [33] Brown, R.E., Stevens, D.R., Haas, H.L., The physiology of brain histamine. Prog. Neurobiol. 63 (2001), 637–672.
34. [34] Donzis, E.J., Tronson, N.C., Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences. Neurobiol. Learn. Mem. 115 (2014), 68–77.
35. [35] Rachal, P.C., Fleshner, M., Watkins, L.R., Maier, S.F., Rudy, J.W., The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci. Biobehav. Rev. 25 (2001), 29–41.
36. [36] Ma, Y., Cheng, Q., Wang, E., Li, L., Zhang, X., Inhibiting tumor necrosis factor-alpha signaling attenuates postoperative cognitive dysfunction in aged rats. Mol. Med. Rep. 12 (2015), 3095–3100.
37. [37] Balschun, D., Wetzel, W., Del, R.A., Pitossi, F., Schneider, H., Zuschratter, W., Besedovsky, H.O., Interleukin-6: a cytokine to forget. FASEB J. 18 (2004), 1788–1790.
38. [38] Bluthe, R.M., Michaud, B., Poli, V., Dantzer, R., Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol. Behav. 70 (2000), 367–373.
39. [39] Winkler, E.A., Bell, R.D., Zlokovic, B.V., Central nervous system pericytes in health and disease. Nat. Neurosci. 14 (2011), 1398–1405.
40. [40] Zlokovic, B.V., Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12 (2011), 723–738.
41. [41] Hamadi, N., Sheikh, A., Madjid, N., Lubbad, L., Amir, N., Shehab, S.A., Khelifi-Touhami, F., Adem, A., Increased pro-inflammatory cytokines, glial activation and oxidative stress in the hippocampus after short-term bilateral adrenalectomy. BMC Neurosci., 17, 2016, 61.
42. [42] Jin, Y., Silverman, A.J., Vannucci, S.J., Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 40 (2009), 3107–3112.
43. [43] Zhang, X., Dong, H., Li, N., Zhang, S., Sun, J., Zhang, S., Qian, Y., Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis. J. Neuroinflamm., 13, 2016.
44. [44] Rozniecki, J.J., Dimitriadou, V., Lambracht-Hall, M., Pang, X., Theoharides, T.C., Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Res. 849 (1999), 1–15.
45. [45] Forsythe, P., Bienenstock, J., The mast cell-nerve functional unit: a key component of physiologic and pathophysiologic responses. Chem. Immunol. Allergy 98 (2012), 196–221.
46. [46] Furuno, T., Ito, A., Koma, Y., Watabe, K., Yokozaki, H., Bienenstock, J., Nakanishi, M., Kitamura, Y., The spermatogenic Ig superfamily/synaptic cell adhesion molecule mast-cell adhesion molecule promotes interaction with nerves. J. Immunol. 174 (2005), 6934–6942.
47. [47] Keller, J.T., Marfurt, C.F., Peptidergic and serotoninergic innervation of the rat dura mater. J. Comp. Neurol. 309 (1991), 515–534.
48. [48] Lambracht-Hall, M., Dimitriadou, V., Theoharides, T.C., Migration of mast cells in the developing rat brain. Brain Res. Dev. Brain Res. 56 (1990), 151–159.
49. [49] Suzuki, R., Furuno, T., McKay, D.M., Wolvers, D., Teshima, R., Nakanishi, M., Bienenstock, J., Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J. Immunol. 163 (1999), 2410–2415.
50. [50] Schwenger, N., Dux, M., de Col, R., Carr, R., Messlinger, K., Interaction of calcitonin gene-related peptide, nitric oxide and histamine release in neurogenic blood flow and afferent activation in the rat cranial dura mater. Cephalalgia 27 (2007), 481–491.
51. [51] Silver, R., Silverman, A.J., Vitkovic, L., Lederhendler, I.I., Mast cells in the brain: evidence and functional significance. Trends Neurosci. 19 (1996), 25–31.
52. [52] Panula, P.P.U.A., Histamine-immunoreac-tive nervefibres in the rat brain. Neuroscience 28 (1989), 585–610.
53. [53] Guo, J., Schofield, G.G., Histamine inhibits KCNQ2/KCNQ3 channel current via recombinant histamine H(1) receptors. Neurosci. Lett. 328 (2002), 285–288.
54. [54] Langlais, P.J., Zhang, S.X., Weilersbacher, G., Hough, L.B., Barke, K.E., Histamine-mediated neuronal death in a rat model of Wernicke's encephalopathy. J. Neurosci. Res. 38 (1994), 565–574.
55. [55] Rozniecki, J.J., Hauser, S., Stein, M., Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37 (1995), 63–66.
56. [56] Dines, K.C., Powell, H.C., Mast cell interactions with the nervous system: relationship to mechanisms of disease. J. Neuropathol. Exp. Neurol. 56 (1997), 627–640.
57. [57] Ossovskaya, V.S., Bunnett, N.W., Protease-activated receptors: contribution to physiology and disease. Physiol. Rev. 84 (2004), 579–621.
58. [58] Kovacs, P., Hernadi, I., Wilhelm, M., Mast cells modulate maintained neuronal activity in the thalamus in vivo. J. Neuroimmunol. 171 (2006), 1–7.
59. [59] Song, N.N., Jia, Y.F., Zhang, L., Zhang, Q., Huang, Y., Liu, X.Z., Hu, L., Lan, W., Chen, L., Lesch, K.P., et al. Reducing central serotonin in adulthood promotes hippocampal neurogenesis. Sci. Rep., 6, 2016, 20338.
60. [60] Watanabe, Y., Gould, E., Daniels, D.C., Cameron, H., McEwen, B.S., Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur. J. Pharmacol. 222 (1992), 157–162.
61. [61] Gould, E., Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 21 (1999), 46S–51S.
62. [62] Morris, J.S., Smith, K.A., Cowen, P.J., Friston, K.J., Dolan, R.J., Covariation of activity in habenula and dorsal raphe nuclei following tryptophan depletion. Neuroimage 10 (1999), 163–172.
63. [63] Shohami, E., Bass, R., Wallach, D., Inhibition of tumor necrosis factor alpha (TNFa) activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 16 (1996), 378–384.
64. [64] Khuman, J., Meehan, W.R., Zhu, X., Qiu, J., Hoffmann, U., Zhang, J., Giovannone, E., Lo, E.H., Whalen, M.J., Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice. J. Cereb. Blood Flow Metab. 31 (2011), 778–789.
65. [65] Bermpohl, D., You, Z., Lo, E.H., Kim, H.H., Whalen, M.J., TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice. J. Cereb. Blood Flow Metab. 27 (2007), 1806–1818.
66. [66] Furuse, M., Molecular basis of the core structure of tight junctions. Cold Spring Harb. Perspect. Biol., 2, 2010, a2907.
67. [67] Gingrich, M.B., Traynelis, S.F., Serine proteases and brain damage – is there a link?. Trends Neurosci. 23 (2000), 399–407.
68. [68] Zlokovic, B.V., The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57 (2008), 178–201.
69. [69] Chan-Ling, T., Hughes, S., Baxter, L., Rosinova, E., McGregor, I., Morcos, Y., van Nieuwenhuyzen, P., Hu, P., Inflammation and breakdown of the blood-retinal barrier during physiological aging in the rat retina: a model for CNS aging. Microcirculation 14 (2007), 63–76.
70. [70] He, H.J., Wang, Y., Le, Y., Duan, K.M., Yan, X.B., Liao, Q., Liao, Y., Tong, J.B., Terrando, N., Ouyang, W., Surgery upregulates high mobility group box-1 and disrupts the blood-brain barrier causing cognitive dysfunction in aged rats. CNS Neurosci. Ther. 18 (2012), 994–1002.
71. [71] Esposito, P., Gheorghe, D., Kandere, K., Pang, X., Connolly, R., Jacobson, S., Theoharides, T.C., Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 888 (2001), 117–127.
72. [72] McKittrick, C.M., Lawrence, C.E., Carswell, H.V., Mast cells promote blood brain barrier breakdown and neutrophil infiltration in a mouse model of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 35 (2015), 638–647.
73. [73] Kermode, A.G., Thompson, A.J., Tofts, P., MacManus, D.G., Kendall, B.E., Kingsley, D.P., Moseley, I.F., Rudge, P., McDonald, W.I., Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 113:Pt. 5 (1990), 1477–1489.
74. [74] Theoharides, T.C., Donelan, J., Kandere-Grzybowska, K., Konstantinidou, A., The role of mast cells in migraine pathophysiology. Brain Res. Brain Res. Rev. 49 (2005), 65–76.
75. [75] Ribatti, D., The crucial role of mast cells in blood-brain barrier alterations. Exp. Cell Res. 338 (2015), 119–125.
76. [76] Lindsberg, P.J., Strbian, D., Karjalainen-Lindsberg, M.L., Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J. Cereb. Blood Flow Metab. 30 (2010), 689–702.
77. [77] Kandere-Grzybowska, K., Gheorghe, D., Priller, J., Esposito, P., Huang, M., Gerard, N., Theoharides, T.C., Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice. Brain Res. 980 (2003), 213–220.
78. [78] Huang, M., Pang, X., Karalis, K., Theoharides, T.C., Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice. Cardiovasc. Res. 59 (2003), 241–249.
79. [79] Huang, M., Pang, X., Letourneau, R., Boucher, W., Theoharides, T.C., Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in Apolipoprotein E knockout mice. Cardiovasc. Res. 55 (2002), 150–160.
80. [80] Kumar, P., Shen, Q., Pivetti, C.D., Lee, E.S., Wu, M.H., Yuan, S.Y., Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev. Mol. Med., 11, 2009, e19.
81. [81] van Hinsbergh, V.W., van Nieuw, A.G., Intracellular signalling involved in modulating human endothelial barrier function. J. Anat. 200 (2002), 549–560.
82. [82] Majno, G., Shea, S.M., Leventhal, M., Endothelial contraction induced by histamine-type mediators: an electron microscopic study. J. Cell Biol. 42 (1969), 647–672.
83. [83] Butt, A.M., Jones, H.C., Effect of histamine and antagonists on electrical resistance across the blood-brain barrier in rat brain-surface microvessels. Brain Res. 569 (1992), 100–105.
84. [84] Mayhan, W.G., Role of nitric oxide in histamine-induced increases in permeability of the blood-brain barrier. Brain Res. 743 (1996), 70–76.
85. [85] Schilling, L., Wahl, M., Opening of the blood-brain barrier during cortical superfusion with histamine. Brain Res. 653 (1994), 289–296.
86. [86] Mayhan, W.G., Regulation of blood-brain barrier permeability. Microcirculation 8 (2001), 89–104.
87. [87] Mauban, J.R.H., Histamine-mediated increases in cytosolic [Ca2+] involve different mechanisms in human pulmonary artery smooth muscle and endothelial cells. AJP: Cell Physiol. 290 (2005), C325–C336.
88. [88] Bregestovski, P., Bakhramov, A., Danilov, S., Moldobaeva, A., Takeda, K., Histamine-induced inward currents in cultured endothelial cells from human umbilical vein. Br. J. Pharmacol. 95 (1988), 429–436.
89. [89] Rozniecki, J.J., Hauser, S.L., Stein, M., Lincoln, R., Theoharides, T.C., Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37 (1995), 63–66.
90. [90] He, S., Walls, A.F., Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation. Eur. J. Pharmacol. 328 (1997), 89–97.
91. [91] Lohi, J., Harvima, I., Keski-Oja, J., Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J. Cell. Biochem. 50 (1992), 337–349.
92. [92] Di Girolamo, N., Indoh, I., Jackson, N., Wakefield, D., McNeil, H.P., Yan, W., Geczy, C., Arm, J.P., Tedla, N., Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration. J. Immunol. 177 (2006), 2638–2650.
93. [93] Fang, K.C., Wolters, P.J., Steinhoff, M., Bidgol, A., Blount, J.L., Caughey, G.H., Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. J. Immunol. 162 (1999), 5528–5535.
94. [94] Yong, V.W., Power, C., Forsyth, P., Metalloproteinases in biology and pathology of theMetalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2 (2001), 502–511.
95. [95] Yang, Y., Estrada, E.Y., Thompson, J.F., Liu, W., Rosenberg, G.A., Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27 (2007), 697–709.
96. [96] Wiggins-Dohlvik, K., Merriman, M., Shaji, C.A., Alluri, H., Grimsley, M., Davis, M.L., Smith, R.W., Tharakan, B., Tumor necrosis factor-α disruption of brain endothelial cell barrier is mediated through matrix metalloproteinase-9. Am. J. Surg. 208 (2014), 954–960.
97. [97] Megyeri, P., Abraham, C.S., Temesvari, P., Kovacs, J., Vas, T., Speer, C.P., Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci. Lett. 148 (1992), 137–140.
98. [98] Sayed, B.A., Christy, A.L., Walker, M.E., Brown, M.A., Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment?. J. Immunol. 184 (2010), 6891–6900.
99. [99] Kempuraj, D., Thangavel, R., Fattal, R., Pattani, S., Yang, E., Zaheer, S., Santillan, D.A., Santillan, M.K., Zaheer, A., Mast cells release chemokine CCL2 in response to parkinsonian toxin 1-Methyl-4-Phenyl-Pyridinium (MPP(+)). Neurochem. Res. 41 (2016), 1042–1049.
100. [100] Stamatovic, S.M., Shakui, P., Keep, R.F., Moore, B.B., Kunkel, S.L., Van Rooijen, N., Andjelkovic, A.V., Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 25 (2005), 593–606.
101. [101] Yao, Y., Tsirka, S.E., Monocyte chemoattractant protein-1 and the blood-brain barrier. Cell. Mol. Life Sci. 71 (2014), 683–697.
102. [102] Strbian, D., Kovanen, P.T., Karjalainen-Lindsberg, M.L., Tatlisumak, T., Lindsberg, P.J., An emerging role of mast cells in cerebral ischemia and hemorrhage. Ann. Med. 41 (2009), 438–450.
103. [103] Konsman, J.P., Parnet, P., Dantzer, R., Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 25 (2002), 154–159.
104. [104] Cao, X.Z., Ma, H., Wang, J.K., Liu, F., Wu, B.Y., Tian, A.Y., Wang, L.L., Tan, W.F., Postoperative cognitive deficits and neuroinflammation in the hippocampus triggered by surgical trauma are exacerbated in aged rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 34 (2010), 1426–1432.
105. [105] Hovens, I.B., van Leeuwen, B.L., Nyakas, C., Heineman, E., van der Zee, E.A., Schoemaker, R.G., Postoperative cognitive dysfunction and microglial activation in associated brain regions in old rats. Neurobiol. Learn. Mem. 118 (2015), 74–79.
106. [106] Barrientos, R.M., Higgins, E.A., Biedenkapp, J.C., Sprunger, D.B., Wright-Hardesty, K.J., Watkins, L.R., Rudy, J.W., Maier, S.F., Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol. Aging 27 (2006), 723–732.
107. [107] Jin, W.J., Feng, S.W., Feng, Z., Lu, S.M., Qi, T., Qian, Y.N., Minocycline improves postoperative cognitive impairment in aged mice by inhibiting astrocytic activation. Neuroreport 25 (2014), 1–6.
108. [108] Tian, A., Ma, H., Zhang, R., Tan, W., Wang, X., Wu, B., Wang, J., Wan, C., Interleukin17A promotes postoperative cognitive dysfunction by triggering beta-Amyloid accumulation via the transforming growth factor-beta (TGFbeta)/Smad signaling pathway. PLoS One, 10, 2015, e141596.
109. [109] Zhang, Y., Chopp, M., Meng, Y., Zhang, Z.G., Doppler, E., Winter, S., Schallert, T., Mahmood, A., Xiong, Y., Cerebrolysin improves cognitive performance in rats after mild traumatic brain injury. J. Neurosurg. 122 (2015), 843–855.
110. [110] Skaper, S.D., Facci, L., Giusti, P., Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review. CNS Neurol. Disord. Drug Targets 13 (2014), 1654–1666.
111. [111] Skuljec, J., Sun, H., Pul, R., Benardais, K., Ragancokova, D., Moharregh-Khiabani, D., Kotsiari, A., Trebst, C., Stangel, M., CCL5 induces a pro-inflammatory profile in microglia in vitro. Cell. Immunol. 270 (2011), 164–171.
112. [112] Feuser, K., Thon, K.P., Bischoff, S.C., Lorentz, A., Human intestinal mast cells are a potent source of multiple chemokines. Cytokine 58 (2012), 178–185.
113. [113] Pietrzak, A., Wierzbicki, M., Wiktorska, M., Brzezinska-Blaszczyk, E., Surface TLR2 and TLR4 expression on mature rat mast cells can be affected by some bacterial components and proinflammatory cytokines. Mediators Inflamm., 2011, 2011, 427473.
114. [114] Chakraborty, S., Kaushik, D.K., Gupta, M., Basu, A., Inflammasome signaling at the heart of central nervous system pathology. J. Neurosci. Res. 88 (2010), 1615–1631.
115. [115] Zhang, H., Yang, H., He, S., TNF increases expression of IL-4 and PARs in mast cells. Cell. Physiol. Biochem. 26 (2010), 327–336.
116. [116] Yuan, H., Zhu, X., Zhou, S., Chen, Q., Zhu, X., Ma, X., He, X., Tian, M., Shi, X., Role of mast cell activation in inducing microglial cells to release neurotrophin. J. Neurosci. Res. 88 (2010), 1348–1354.
117. [117] Zhang, H., Lin, L., Yang, H., Zhang, Z., Yang, X., Zhang, L., He, S., Induction of IL-13 production and upregulation of gene expression of protease activated receptors in P815 cells by IL-6. Cytokine 50 (2010), 138–145.
118. [118] Zhang, S., Zeng, X., Yang, H., Hu, G., He, S., Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling. Cell. Physiol. Biochem. 29 (2012), 931–940.
119. [119] Dong, H., Zhang, W., Zeng, X., Hu, G., Zhang, H., He, S., Zhang, S., Histamine induces upregulated expression of histamine receptors and increases release of inflammatory mediators from microglia. Mol. Neurobiol. 49 (2014), 1487–1500.
120. [120] Zhang, X., Wang, Y., Dong, H., Xu, Y., Zhang, S., Induction of microglial activation by mediators released from mast cells. Cell. Physiol. Biochem. 38 (2016), 1520–1531.
121. [121] Dong, H., Zhang, X., Wang, Y., Zhou, X., Qian, Y., Zhang, S., Suppression of brain mast cells degranulation inhibits microglial activation and central nervous system inflammation. Mol. Neurobiol., 2016, 10.1007/s 12035-016-9720-x Epub ahead of print.
122. [122] Rocha, S.M., Pires, J., Esteves, M., Graca, B., Bernardino, L., Histamine: a new immunomodulatory player in the neuron-glia crosstalk. Front. Cell. Neurosci., 8, 2014, 120.
123. [123] Soruri, A., Grigat, J., Kiafard, Z., Zwirner, J., Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor. BMC. Immunol., 9, 2008, 29.
124. [124] Gasque, P., Singhrao, S.K., Neal, J.W., Gotze, O., Morgan, B.P., Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150 (1997), 31–41.
125. [125] Kim, D.Y., Jeoung, D., Ro, J.Y., Signaling pathways in the activation of mast cells cocultured with astrocytes and colocalization of both cells in experimental allergic encephalomyelitis. J. Immunol. 185 (2010), 273–283.
126. [126] Khalil, M., Ronda, J., Weintraub, M., Jain, K., Silver, R., Silverman, A.J., Brain mast cell relationship to neurovasculature during development. Brain Res. 1171 (2007), 18–29.
127. [127] Kim, D.Y., Hong, G.U., Ro, J.Y., Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J. Neuroinflammation, 8, 2011, 25.
128. [128] Hosli, L., Hosli, E., Schneider, U., Wiget, W., Evidence for the existence of histamine H1- and H2-receptors on astrocytes of cultured rat central nervous system. Neurosci. Lett. 48 (1984), 287–291.
129. [129] Zeng, X., Zhang, S., Xu, L., Yang, H., He, S., Activation of protease-activated receptor 2-mediated signaling by mast cell tryptase modulates cytokine production in primary cultured astrocytes. Mediators Inflamm., 2013, 2013, 140812.
130. [130] Barres, B.A., The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60 (2008), 430–440.
131. [131] Allen, N.J., Barres, B.A., Neuroscience: Glia – more than just brain glue. Nature 457 (2009), 675–677.
132. [132] De Keyser, J., Mostert, J.P., Koch, M.W., Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J. Neurol. Sci. 267 (2008), 3–16.
133. [133] Sofroniew, M.V., Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32 (2009), 638–647.
134. [134] Waisman, A., Liblau, R.S., Becher, B., Innate and adaptive immune responses in the CNS. Lancet Neurol. 14 (2015), 945–955.
135. [135] Chen, W.W., Zhang, X., Huang, W.J., Role of neuroinflammation in neurodegenerative diseases (Review). Mol. Med. Rep. 13 (2016), 3391–3396.
136. [136] Maslinska, D., Laure-Kamionowska, M., Maslinski, K.T., Gujski, M., Maslinski, S., Distribution of tryptase-containing mast cells and metallothionein reactive astrocytes in human brains with amyloid deposits. Inflamm. Res. 56:Suppl. 1 (2007), S17–S18.
137. [137] Piette, F., Belmin, J., Vincent, H., Schmidt, N., Pariel, S., Verny, M., Marquis, C., Mely, J., Hugonot-Diener, L., Kinet, J.P., et al. Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial. Alzheimers Res. Ther., 3, 2011, 16.
138. [138] Silver, R., Curley, J.P., Mast cells on the mind: new insights and opportunities. Trends Neurosci. 36 (2013), 513–521.
139. [139] Secor, V.H., Secor, W.E., Gutekunst, C.A., Brown, M.A., Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191 (2000), 813–822.
140. [140] Medic, N., Vita, F., Abbate, R., Soranzo, M.R., Pacor, S., Fabbretti, E., Borelli, V., Zabucchi, G., Mast cell activation by myelin through scavenger receptor. J. Neuroimmunol. 200 (2008), 27–40.